Affimed N.V. (NASDAQ:AFMD) Q1 2022 Results Conference Call June 1, 2022 8:30 AM ET

Company Participants

Alex Fudukidis - Head of Investor Relations

Adi Hoess - Chief Executive Officer

Andreas Harstrick - Chief Medical Officer

Arndt Schottelius - Chief Scientific Officer

Wolfgang Fischer - Chief Operating Officer

Angus Smith - Chief Financial Officer

Conference Call Participants

Daina Graybosch - SVB Securities

Kripa Devarakonda - Truist Securities

Maury Raycroft - Jefferies

Li Watsek - Cantor

Brad Canino - Stifel

Do Kim with - Sandler

Yale Jen - Laidlaw

Nick Abbott - Wells Fargo

Operator

Good day and thank you for standing by. Welcome to the Affimed First Quarter 2022 Financial Results Corporate Update Conference Call. At this time, all participant lines are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]

I would now like to hand the conference over to Alex Fudukidis, Head of Investor Relations. Please go ahead, sir.

Alex Fudukidis

Thank you, Norma, and thank you all for joining us for our call today. Before we begin, I'd like to remind everyone that we posted the relevant press release and presentation on the Investor Relations section of our website earlier today. On the call today, we have the members of our management team, including Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Arndt Schottelius, our Chief Scientific Officer; Wolfgang Fischer, our Chief Operating Officer; and Angus Smith, our Chief Financial Officer. The team will be available for the Q&A after the prepared remarks.

Before we start, I would like to remind you that today's presentation contains projections and forward-looking statements regarding future events. These statements represent our beliefs and assumptions only as of the date of this call. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future.

These forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in these statements due to various factors including, but not limited to, those identified under the section entitled Risk Factors in our filings with the SEC and those identified under the section entitled forward-looking statements in the press release that we issued today and filed with the SEC.